You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 14, October 11, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In the Combined Pharmacotherapies and Behavioral Interventions (COMBINE) Study, Dr Anton and colleagues1 evaluated the effects of combining medications with behavioral interventions in treatment of alcohol dependence. While all 9 study groups showed marked reductions in drinking from baseline to end of study, treatment with acamprosate, naltrexone, or both when added to the background of medical management did not substantially improve percent days abstinent or time to first heavy drinking day (the 2 coprimary outcomes) compared with placebo and medical management, regardless of whether a combined behavioral intervention (CBI) was added.

In this multifactorial design, naltrexone statistically separated from nonnaltrexone groups on time to severe relapse but demonstrated a significant interaction with CBI for percent days abstinent. The direction of interaction indicatedthat the medication effect was weaker when CBI was added, an unexpected finding. Furthermore, the magnitude of additional benefits of naltrexone over placebo with medical management . . . [Full Text of this Article]

Jeffrey M. Jonas, MD
jeffrey.jonas@frx.com
Forest Research Institute
Jersey City, NJ

Sylvie Chabac, MD, MBA
Merck Santé
Lyon, France


RELATED ARTICLES

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
Falk Kiefer and Karl Mann
JAMA. 2006;296(14):1727-1728.
EXTRACT | FULL TEXT  

Pharmacotherapy and Behavioral Intervention for Alcohol Dependence—Reply
Raymond F. Anton, William R. Miller, Stephanie S. O’Malley, Allen Zweben, and James D. Hosking
JAMA. 2006;296(14):1728-1729.
EXTRACT | FULL TEXT  

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Raymond F. Anton, Stephanie S. O’Malley, Domenic A. Ciraulo, Ron A. Cisler, David Couper, Dennis M. Donovan, David R. Gastfriend, James D. Hosking, Bankole A. Johnson, Joseph S. LoCastro, Richard Longabaugh, Barbara J. Mason, Margaret E. Mattson, William R. Miller, Helen M. Pettinati, Carrie L. Randall, Robert Swift, Roger D. Weiss, Lauren D. Williams, Allen Zweben, and for the COMBINE Study Research Group
JAMA. 2006;295(17):2003-2017.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.